Article Text
Abstract
The present work critically examines two assumptions frequently stated by supporters of cognitive neuroenhancement. The first, explicitly methodological, assumption is the supposition of effective and side effect-free neuroenhancers. However, there is an evidence-based concern that the most promising drugs currently used for cognitive enhancement can be addictive. Furthermore, this work describes why the neuronal correlates of key cognitive concepts, such as learning and memory, are so deeply connected with mechanisms implicated in the development and maintenance of addictive behaviour so that modification of these systems may inevitably run the risk of addiction to the enhancing drugs. Such a potential risk of addiction could only be falsified by in-depth empirical research. The second, implicit, assumption is that research on neuroenhancement does not pose a serious moral problem. However, the potential for addiction, along with arguments related to research ethics and the potential social impact of neuroenhancement, could invalidate this assumption. It is suggested that ethical evaluation needs to consider the empirical data as well as the question of whether and how such empirical knowledge can be obtained.
- Neuro-enhancement
- addiction
- neuroethics
- research ethics
- applied and professional ethics
- philosophical ethics
- enhancement
- embryos and fetuses
- living wills/advance directives
Statistics from Altmetric.com
Footnotes
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Linked Articles
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Neuroenhancers, addiction and research ethics
- Neuropsychiatry of the basal ganglia
- True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Sugar addiction: is it real? A narrative review
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Psychostimulant effect of levodopa: reversing sensitisation is possible
- The use of methylphenidate among students: the future of enhancement?
- A selective literature review exploring the role of the nicotinic system in schizophrenia
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology